Gene Editing of Embryos Gives Insight Into Basic Human Biology
By Marissa Fessenden,
Smithsonian.com [cites CGS' Marcy Darnovsky]
| 09. 21. 2017
A genetic tool allows researchers to disable a gene key to human development in a closely regulated experiment
For the first time, scientists edited a gene in fertilized human eggs critical to early development. The experiments helped the researchers learn about fundamental human biology in a way they could not through research on mice.
Researchers led by Kathy Niakan, a developmental biologist at the Francis Crick Institute in London, disabled a gene that codes for a protein called OCT4, known to be active in stem cells that can develop into all the cell types found in the body, reports Gretchen Vogel for Science. Turning the gene off ensured that cells from fertilized human eggs failed to form placental cells, yolk sac cells or even cells that would typically become a fetus.
Disabling the same gene in mouse embryos gives different results: Those embryos became balls of mostly placental cells. The findings suggest that the gene controls the fate of several cell lineages and plays a slightly different role in humans than in mice.
"This is opening up the possibility...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...